Presentation TCT 2016 Flash Perspective: The Best Way to Become a (New) CHIP Operator: When, Where, How, and Why to Train: A Mid-Career Perspective - On-the-job Training With Proctoring Is the Most Reliable Method! Presenter: Emmanouil S. Brilakis, Jeffrey W. Moses October 31, 2016
Presentation TCT 2016 Non-Culprit Lesion Chronic Total Occlusions in STEMI: Should We Open Them? Presenter: Ran Kornowski, Michel R. Le May, Jose P.S. Henriques October 31, 2016
Presentation TCT 2016 Public Reporting, Appropriateness Criteria, and the CHIP Initiative: At Odds or Working Together? Presenter: Emmanouil S. Brilakis, Jeffrey W. Moses, Robert W. Yeh October 31, 2016
Presentation TCT 2016 Introductory Lecture: Defining CHIP/Complex PCI in 2016 - Where We Are and Where We Need to Go Presenter: Emmanouil S. Brilakis, Jeffrey W. Moses October 31, 2016
Presentation TCT 2016 Primary PCI in Patients With Multivessel Disease: Overview of Randomized Trials and Unanswered Questions Presenter: Ran Kornowski, Michel R. Le May, Kevin Bainey October 31, 2016
Presentation TCT 2016 TCT 67: Impact of the SYNTAX Score in Patients With Diabetes and Left-Main and/or Multivessel Coronary Disease: A Pooled Analysis of Individual Patient Level Data From the SYNTAX, PRECOMBAT and BEST Trials Presenter: Sorin J. Brener, Jean-François Tanguay, Rafael Cavalcante October 31, 2016
Presentation TCT 2016 Have Contemporary DES Narrowed the Gap With CABG in Multivessel Disease? From BEST to SYNTAX II and Beyond Presenter: Dean J. Kereiakes, Pieter C. Smits, Patrick W. Serruys October 30, 2016
News Conference News TCT 2016 LEADERS FREE: Polymer-Free DES Maintains Superior Safety, Efficacy Over BMS at 2 Years Yael L. Maxwell October 30, 2016
News Conference News TCT 2016 YELLOW II: Improved Cholesterol Efflux Linked to Plaque Stabilization in Statin-Treated Patients Michael O'Riordan October 29, 2016
Presentation TCT 2015 BRS in Multivessel Disease Presenter: David W.M. Muller, Ashok Seth, Robert-Jan van Geuns October 15, 2015
Presentation TCT 2015 Pros and Cons of CABG vs PCI in the Diabetic Patient With Multivessel Disease: Insights From Randomized Trials Presenter: Frederick Feit, David J. Maron, Michael E. Farkouh October 15, 2015
Presentation TCT 2015 New Approaches for Diffuse Disease: DEB, BRS, and Beyond Presenter: Jeffrey W. Moses, Erick Schampaert, Giuseppe Tarantini October 14, 2015
Presentation TCT 2015 SVG Intervention: Is Distal Protection Still Needed? And Should We Always Do the Native Vessel Instead? Presenter: Jeffrey W. Moses, Erick Schampaert, Dimitri Karmpaliotis October 14, 2015
Presentation TCT 2015 Debate: Should Atheroablation Be Used More Often? Yes, Atheroablation Is Underutilized! Presenter: Jeffrey W. Moses, Erick Schampaert, Nabil Dib October 14, 2015
Presentation TCT 2015 Debate: Should Atheroablation Be Used More Often? No, the Present Evidence Says It Should Be Used Sparingly! Presenter: Jeffrey W. Moses, Erick Schampaert, Gert Richardt October 14, 2015
Presentation TCT 2015 Atheroablation: Current Technologies and Techniques Presenter: Jeffrey W. Moses, Erick Schampaert, Mohamed Abdel-Wahab October 14, 2015
Presentation TCT 2015 CTO in Patients With Left Main and Multivessel Disease: Why and When to Treat Presenter: Jeffrey W. Moses, Erick Schampaert, Barry D. Rutherford October 14, 2015
Presentation TCT 2015 Sorting Through Revascularization Choices in Left Main and Multivessel Disease: A Practical Approach Presenter: Jeffrey W. Moses, Erick Schampaert October 14, 2015
Presentation TCT 2015 Just How Effective Is Hypothermia in Cardiac Arrest? Presenter: Tanveer Rab, Holger Thiele, Michel R. Le May October 14, 2015
Presentation TCT 2015 The Role (and Timing) of Complete Revascularization in AMI and Cardiogenic Shock Presenter: Tanveer Rab, Holger Thiele October 14, 2015